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MacGowan, O'Hourihane, Tanner, O'Morain
in 10 risk of intestinal lymphoma in a newly
diagnosed patient with coeliac disease.'0 Ex-
actly how and why coeliac disease is associated
with an increased risk of lymphomatous and
carcinomatous change remains unknown. Sev-
eral explanations have been put forward. The
mucosal damage in coeliac disease may make
the small intestine more permeable to environ-
mental carcinogens which, with associated
malabsorptive vitamin A deficiency and in-
creased vulnerability to oxidative injury, would
enhance carcinogenic change. Known predis-
posing factors for the development of small
intestinal adenocarcinoma include Crohn's
disease, adenomatous polyps and Peutz-
Jeugher's syndrome.4 Perzin et al" reported
that 23 of 51 cases of small intestinal adeno-
carcinoma had evidence of adenoma and carci-
noma in the same lesion. Survival is dependent
on the presence or absence of nodal involve-
ment at presentation. Five year survival with
node negative disease is 68%, while the overall
figure varies from 15 to 20%.12 Thus, as the
prognosis is not uniformly poor and some
patients are potentially curable by total resec-
tion (as in patient 2 in the present paper), lim-
iting postoperative morbidity and recognising
potential complications becomes very impor-
tant. Clinically unmasked coeliac disease com-
plicating Whipple's resection has not been
described before and these two cases illustrate
the importance of early diagnosis and dietary
intervention prior to surgery. Previous cases of
failure to thrive and weight loss following
Whipple's resection may be simply put down to
the effects of small bowel resection, pancreatic
insufficiency, tumour progression, or early
recurrence. Underlying coeliac disease should
also be considered and the tumour-free mu-
cosal margins carefully inspected.
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Abstract
A case of a 64 year old woman with a
tumour of the uterus is reported. The
patient presented with postmenopausal
bleeding and subsequently underwent
total hysterectomy and bilateral salpingo-
oophorectomy. Sections of the tumour
showed a low grade endometrial stromal
sarcoma coexisting with areas consistent
with high grade sarcoma. The sarcoma
cells, in both the low and high grade areas,
were positive for vimentin and negative
for desmin and cytokeratin on immuno-
histochemistry. While the sarcoma cells in
the low grade region showed immunore-
activity for oestrogen and progestogen
receptors, those in the high grade region
did not. Using chromosome in situ hy-
bridisation, the low grade portion of the
sarcoma was diploid for chromosomes X,
11, 12, and 17, whereas the more anaplas-
tic areas were aneuploid for these chro-
mosomes. This case may represent an
example of high grade endometrial stro-
mal sarcoma arising by dedifferentiation
from a low grade stromal sarcoma. Ad-
equate sampling is important in identify-
ing such anaplastic changes as the origin
of the tumour will affect patient manage-
ment.
(7 Clin Pathol 1996;49:604-607)
Keywords: endometrial stromal sarcoma, dedifferentia-
tion.
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Figure 1 Photomicrograph showing the interface between the
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Figure 2 Two in situ hybridisation signals were detected in th
after hybridisation with a DNA probe specific for chromosome
Endometrial stromal
stromal nodules and
stromal sarcomas, have
and cytological feature
iour.' 2 They also vary
response to treatment. I
of uterine high grade str
ing with, and probably
low grade endometrial
like soft tissue tumours,
tion has rarely been repc
sarcomas.45 Comparati
hormone receptor exprn
analysis have not been
such cases.
Case report
A 57 year old woman,
primary infertility, pres
pausal bleeding of two i
patient's uterus was (
examination. An endonr
insufficient material for diagnosis. A total
;>itj%Y..'>/X^ hysterectomy and bilateral salpingo-oophor-
sr $vg,--A tX,, ectomy were carred out subsequently.
Vr$-=*tt:-f3ffiwe# The uterus weighed 240 g and its anterior
* $ S}4t wall was thickened by an ill defined tumour
c, mass, 4 cm diameter, which completely obliter-
i ated the endometrial cavity. Sectioning re-
IL;t 3t;X^£ vealed whitish tumour tissue with patchy
necrosis. The patient's ovaries and fallopian
<ix.*;p,c/ > tubes were unaffected.
*O>^1|4 Most sections of the tumour mass showed
monotonous sheets of cells traversed by
ramifying small vessels. The tumour cells had
* scanty cytoplasm and ovoid nuclei resembling
tr'4;t~ those of endometrial stromal cells. The mitotic2 count in these areas was about three per 10
high power fields (hpf). Vascular permeation
V44f J*f; was present. Epithelioid differentiation in the
*w^ b -t4X. form of fine trabecular cords was present
t * focally. Therefore, the features of the major
low grade (L) and high portion of the tumour were those of a low
grade endometrial sarcoma. Tumour close to
the endometrial surface showed foci with obvi-
ous anaplastic changes. The tumour cells in
these more anaplastic foci were large and pleo-
morphic with large hyperchromatic nuclei and
prominent nucleoli. The mitotic count was
.j about 18/10 hpf. Heterologous elements could
not be detected. The features in these foci were
consistent with a high grade stromal sarcoma.
An endometrial stromal sarcoma with both
/ *+. low and high grade features was diagnosed (fig
1). The patient received postoperative pelvic
* ,* ^ irradiation. She is well 18 months after
*~ * w treatment.
' IMMUNOHISTOCHEMISTRY
tv 'I Standard immunohistochemical studies were
performed on formalin fixed, paraffin wax
embedded tissue sections using the Streptavi-
din biotin and diaminobenzidine peroxidase
lowgrad:ro:ar
antiperoxidase technique (Dako, Glostrup,
Denmark). Antibodies used were directed
e low grade sarcoma area against desmin (Dako), vimentin (Dako),
12 (arrows). CAM 5.2 (Becton Dickinson, USA), Mak 6
cytokeratin (Triton, USA), AE1/3 (BioGenex,
USA), oestrogen receptor (Dako), and pro-
neoplasms, including gestogen receptor (Abbott Laboratories, UK).
low and high grade Paraffin wax sections were pretreated in a
different architectural microwave oven (Bio-Rad H2500, USA) be-
s and clinical behav- fore being stained for oestrogen and pro-
with respect to their gestogen receptors.
Here, we report a case The tumour cells in both the low and high
romal sarcoma coexist- grade regions were positive for vimentin but
arising from, adjacent negative for the cytokeratins and desmin, sup-
stromal sarcoma. Un- porting the histological diagnosis of endome-
3tumour dedifferentia- trial stromal sarcoma. The low grade portion of
)rted in uterine stromal the sarcoma showed immunoreactivity for both
ive studies of steroid oestrogen and progestogen receptors while the
ession and cytogenetic high grade sarcoma was negative for both hor-
lescribed previously in mone receptors.
with a long history of
ented with postmeno-
months' duration. The
enlarged on physical
ietrial aspirate yielded
CHROMOSOME IN SITU HYBRIDISATION
The chromosome in situ hybridisation method
used in the present study was a modification of
a protocol used for detecting chromosome
copy numbers in routinely processed, paraffin
wax tissue sections.6 7 Briefly, the DNA probes
specific for chromosomes 11 (D 11Z1), 12
(D12Z3), 17 (D17Z1) (American Type Cul-
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Figure 3 Multiple in situ hybridisation signals were observed in the high grade sarco
after hybridisation with a DNA probe specific for chromosome 12 (arrows).
ture Collection, USA), and the X chromos
(pBamX5) (generous gift from DrAHN ]
man) were labelled with biotin via nick tra
tion (Boehringer, USA). Immunohistoche
try was carried out using avidin, biotiny
mouse anti-avidin, rabbit anti-mouse pe
dase, and 3,3'-diaminobenzidine (Dako,:
Wycombe, UK) to visualise peroxidase act
The slides were then counterstained with
matoxylin and mounted.
At least 500 nuclei were assessed in the
grade and high grade portions of the sarc
The number of chromosome specific in
hybridisation signals was evaluated as
scribed previously.6 7 Uterine smooth m
cells present in the tissue sections acted a
internal control for normal diploid XX ce
In areas of low grade sarcoma, less than
of the cells had more than two copies of
mosomes X, 11, 12, and 17 (fig 2). In con
over 60% of cells in areas of high
sarcoma contained more than two copi
these four chromosomes. Some cells contE
up to eight or nine signals (fig 3).
Discussion
Dedifferentiation is a well recognised phei
enon in bone and soft tissue tumours, wh
high grade tumour coexists with a relal
low grade and well differentiated malii
tumour of the same origin. It is regarded
histological indicator of tumour progre
when a low grade tumour transforms ii
poorly differentiated and more mali~
tumour.3 However, dedifferentiation has I
been described in uterine stromal sarc
Review of literature revealed that only
cases of coexisting low grade and high j
uterine stromal sarcomas have been
ported.4 5 Two cases of high grade stroma
coma have been reported, one arising fror
sarcomatous overgrowth of a low grade n
rian adenosarcoma and the other follc
radiotherapy for low grade endometrial
mal sarcoma.9 Details of oestrogen and
gestogen receptor expression and the k
type in these cases were not given. In the
reported here, the uterine tumour was a low
grade stromal sarcoma, with transition to high
s%. grade stromal sarcoma at the peripheral
portion of the tumour lining the endometrium.
Immunoreactivity for both oestrogen and
progesterone receptors was noted in the part of
the tumour with appearances histologically
diagnostic of low grade stromal sarcoma. The
~ high grade tumour was negative for both
*FF steroid hormone receptors. This is consistent
with previous immunohistochemical studies by
other investigators.'0 Such differential expres-
sion of hormone receptors may explain differ-
ences in response to hormone therapy. It has
been reported that complete or partial resolu-
tion of recurrent or metastatic low grade
stromal sarcoma can occur after treatment with
progestogens.' 2 4 These reports have led to the
recommendation that women with low grade
stromal sarcoma should be treated by total
ma abdominal hysterectomy and bilateral sal-
pingo-oophorectomy followed by long term
progestogen therapy. Alternative treatment
some such as radiotherapy should only be considered
1oP- for women whose neoplasms do not contain
nsla- significant amounts of progestogen receptors
"mis- or are resistant to progestogens. Progestogens
lated are generally of little effect in patients with high
roxi- grade stromal sarcoma. Surgery combined
High with preoperative or postoperative pelvic radia-
:ivity. tion is currently recommended as the most
hae- effective mode of treatment.
Using chromosome in situ hybridisation, we
e low demonstrated that the low grade sarcoma in
:oma. the present case was diploid for chromosomes
situ X, 11, 12, and 17, whereas the high grade area
,
de- was aneuploid. These findings are consistent
uscle with flow cytometry studies reported in the lit-
s the erature"': stromal nodules and low grade sarco-lls. mas are generally diploid whereas most high
15% grade stromal sarcomas are aneuploid. The
chro- prognostic significance of aneuploidy in uter-
trast, ine stromal sarcoma has not been defined con-
grade clusively as yet.2 11
es of This case report also emphasises that
lined adequate sampling is important in detecting
anaplastic differentiation of an apparently low
grade tumour, especially if the high grade
tumour comprises a relatively small part of the
nom- tumour mass. Recognition of dedifferentiation
ere a significantly affects treatment and prognosis as
tively the high grade portion of the stromal sarcoma
gnant is unlikely to respond to progestogen treat-
I as a ment.
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Iododeoxyuridine labelling of S-phase fraction in
fine needle aspirates from breast carcinomas
RA Maas, P F Bruning, A J Breedijk, J L Peterse
Abstract
The suitability of measuring the S-phase
fraction in human breast cancer by label-
ling tumour cells from fine needle aspi-
rates (FNAs) in vitro with iododeoxyurid-
ine (IdU) was studied in 11 patients. The
S-phase fraction was measured both in
preoperative FNAs labelled in vitro with
IdU, and in FNAs taken from the same
tumour when surgically removed after
intravenous administration ofIdU. Frozen
sections were also immunostained for
incorporated IdU. The mean S-phase
fraction measured in FNAs after in vitro
or in vivo labelling and in sections after in
vivo labelling was 4.0, 3.6, and 3.1, respec-
tively. Results ofin vitro and in vivo label-
ling of FNAs with IdU were similar. How-
ever, as the S-phase fraction in breast
cancer is generally low, the variation
between the different measurements is too
large; therefore, the S-phase fraction is
not a suitable indicator of response to
treatment.
(7 Clin Pathol 1996;49:607-609)
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Decreasing proliferative activity in tumours
could be used as an early indication ofresponse
to systemic treatment. Changes in S-phase
fraction as a measure of the proliferative activ-
ity could be monitored in sequentially obtained
fine needle aspirates (FNAs). Immunostaining
of iododeoxyuridine (IdU) incorporated into
the DNA in the S-phase of the cell cycle offers
a sensitive and specific method to assess
S-phase fraction in FNAs from breast tumours.
In vivo labelling of tumour cells requires the
intravenous administration of IdU. Apart from
the discomfort to the patient and costs
involved, IdU administration may in turn cause
further mutation. Moreover, the optimal tim-
ing of IdU administration varies from patient
to patient. In vitro labelling with IdU is an
attractive alternative.
Methods
idu LABELLING
The S-phase fraction was measured in 17
patients with primary breast cancer. FNAs
were taken from the primary breast carcinomas
on the day before surgical removal of the
tumour. Viable carcinoma cells were counted
using the trypan blue exclusion test. The
tumour cells were labelled in vitro by being
incubated at 37°C for two hours in DMEM
culture medium (Gibco BRL, Breda, The
Netherlands) containing 10% fetal calf serum
(Gibco BRL) and 10 jiM IdU (Sigma, Axel,
The Netherlands). Approximately six hours
before surgery the patients received an
intravenous infusion of 100 mg IdU in 50 ml.
Directly after surgical removal of the tumour a
second FNA was taken for the analysis of in
vivo labelling. FNAs were washed in phosphate
buffered saline (PBS), resuspended in 70%
alcohol and stored at 4°C pending analysis.
Tumour tissue was snap frozen in liquid nitro-
gen until further processing.
Permission to administer IdU was obtained
from the Medical Ethical Committee of the
Antoni van Leeuwenhoekhuis. Informed con-
sent was obtained from each patient.
IMMUNOCYTOCHEMICAL STAINING FOR idu
Cytospin preparations were prepared, dried
and washed in PBS. After being washed in
PBS, frozen tumour sections were treated in
the same way as the cytospin preparations. All
samples were incubated in 95% formamide in
PBS at 70°C for 45 minutes, washed three
times for five minutes in 0.1 M Tris/HCl (pH
7.6) supplemented with 5% Tween 20, fol-
lowed by a 10 minute wash in Tris/HCl (pH
7.6). After preincubation for 15 minutes in
PBS supplemented with 0.5% Tween 20, 0.1%
bovine serum albumin (BSA) and 10% normal
rabbit serum, the preparations were incubated
at room temperature with anti-IdU murine
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